Amneal Pharmaceuticals Earnings
NASDAQ: AMRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Oct 29, 2026
Fiscal period
Sep/2026
EPS estimate
$0.21
Amneal Pharmaceuticals earnings summary
Amneal Pharmaceuticals is scheduled to report Sep/2026 earnings on Oct 29, 2026, with analysts expecting EPS of $0.21. In its most recent report on Aug 6, 2026 (Q2 2026), AMRX posted EPS of $0.18. Revenue for the quarter was $796.2 million.
Quarterly EPS is up 157.1% from the same quarter a year earlier. Across the last 16 reports, AMRX shares moved an average of 7.1% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
AMRX earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $0.18 | — | +0.1% |
| May 7, 2026 | — | $0.19 | — | -9.6% |
| Feb 27, 2026 | — | $0.10 | — | -4.1% |
| Nov 6, 2025 | — | $0.01 | — | +2.4% |
| Aug 7, 2025 | — | $0.07 | — | +10.7% |
| May 7, 2025 | — | $0.04 | — | +2.6% |
| Feb 28, 2025 | — | $-0.10 | — | +2.7% |
| Nov 12, 2024 | — | $0.00 | — | -0.9% |
| Aug 9, 2024 | — | $0.02 | — | +5.1% |
| May 8, 2024 | — | $-0.30 | — | +2.4% |
| Mar 14, 2024 | — | $-0.57 | — | +10.4% |
| Nov 9, 2023 | — | $0.06 | — | +7.3% |
| Aug 8, 2023 | — | $0.08 | — | -6.0% |
| May 9, 2023 | — | $-0.05 | — | +20.3% |
| Mar 3, 2023 | — | $-0.03 | — | -20.3% |
| Nov 7, 2022 | — | $-0.02 | — | -8.9% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.